Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma

Oncogene

Volumn 12, Issue 12, 1996, Pages 2527-2533

  Ray, Michael E ^a,b   Su, Yan A ^b   Meltzer, Paul S ^b   Trent, Jeffrey M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Chromosome 6; Malignant melanoma; Tumor suppression

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER INHIBITION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 6; GENE ISOLATION; GENETIC ANALYSIS; IN SITU HYBRIDIZATION; MELANOCYTE; MELANOMA; MELANOMA CELL; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; TUMOR CELL LINE;

BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; DNA, COMPLEMENTARY; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

RODENTIA;

EID: 0030010990     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 1987 Annual Cancer Statistic Review-Including Cancer Trends: 1950-1985. (1988). Bethesda, MD: National Cancer Institute, NIH Publication No. 88-2789.
2. Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ. (1990). J. Mol. Biol., 215, 403-410.
3. Brown T. (1993). Current Protocols in Molecular Biology, Vol. 1, Supplement 23, pp. 4.9.1-4.9.14. Ausubel FM (ed.). Current Protocols: Greene Publishing Associates and John Wiley & Sons, Inc.
4. Engebrecht J and Brent R. (1991). Current Protocols in Molecular Biology, Vol. 1, Supplement 15, pp. 1.6.1-1.6.2. Ausubel FM. (ed.). Current Protocols: Greene Publishing Associates and John Wiley & Sons, Inc.
5. Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y and Halaban R. (1992). Mol. Biol. Cell, 3, 197-209.
6. Gish W and States DJ. (1993). Nature Genet., 3, 266-272.
7. Halaban R. (1993). Recent Res. Cancer Res., 128, 133-150.
8. Jackson IJ. (1994). Annu. Rev. Genet., 28, 189-217.
9. Kingston RE. (1991). Current Protocols in Molecular Biology, Vol. 1, Supplement 14, pp. 4.2.1-4.2.4. Ausubel FM. (ed.). Current Protocols: Greene Publishing Associates and John Wiley & Sons, Inc.
10. Lassam N and Bickford S. (1992). Oncogene, 7, 51-56.
11. Martin FH, Suggs S, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin CH, Cupples RL and Zsebo KM. (1990). Cell, 63, 203-211.
12. Mathew S, Murty VVVS, Hunziker W and Chaganti RSK. (1992). Genomics, 14, 775-779.
13. Meltzer PM, Guan ZY and Trent JM. (1993). Nature Genet., 4, 252-255.
14. Millikin D, Meese E, Vogelstein B, Witkowski C and Trent J. (1991). Cancer Res., 51, 5449-5455.
15. Natali PG, Nicotra MR, Winkler AB, Cavaliere R, Bigotti A and Ullrich A. (1992). Int. J. Cancer, 52, 197-210.
16. Thompson FH, Emerson J, Olson S, Weinstein R. Leavitt SA, Leong SP, Emerson S, Trent JM, Nelson MA, Salmon SE and Taetle R. (1995). Cvtogenet. Cell Genet., 83, 93-104.
17. Trent J. Thompson FH and Meyskens Jr. FL. (1989). Cancer Res., 49, 420-423.
18. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM and Nable RB. (1990). Science, 247, 568-571.
19. Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Parsons PG and Hayward NK. (1994). Int. J. Cancer, 58, 203-206.
20. Wang Z and Brown DD. (1991). Proc. Natl. Acad. Sci. USA, 88, 11505-11509.
21. Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ and Weissman BE. (1994). Oncogene, 9, 255-262.